KyoungHyun Kim

KyoungHyun Kim is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He leads a research program focused on nuclear receptor NR2E3 in liver diseases/cancer and aryl hydrocarbon receptor (AHR) in pancreatic diseases. Dr. Kim holds a Ph.D. from Texas A&M University and completed postdoctoral training at the University of San Diego and MD Anderson Cancer Center.

Education:

• M.S., Rutgers University (1996–1998)
• Ph.D., Texas A&M University (1998–2004)
• Postdoctoral Fellowships: University of San Diego (2004–2006), MD Anderson Cancer Center (2006–2008)

Research Interests:

• NR2E3’s role in liver cancer epigenetic regulation and sex-dependent disease outcomes
• AHR-mediated environmental toxin signaling in pancreatic cancer progression
• Development of NR2E3 as a prognostic biomarker and therapeutic target

Grants & Funding:

• UAMS College of Medicine Startup Funds (2022–present)
• NIEHS P30 ES006096 Center Award (2019–2020)
• University of Cincinnati Faculty Research Grant (2019–2020)

Laboratory: Located in Cancer Institute CI3329, Room 308. Current projects emphasize translating NR2E3/AHR research into precision medicine strategies for liver and pancreatic cancers.